Despite the pressing need for appropriate treatments, the investment landscape is not amenable to therapeutic development. In an Endpoints webinar hosted on September 15th, speakers will discuss the current state of rare disease drug development funding and how the industry can foster innovation in spite of these difficulties.
According to Endpoints Webinar, key points will include:
“Learn about the current state of investments for the rare disease sector
Understand the market’s effect on innovation in rare disease
Hear from leading experts on what we do as a community to help drive innovation forward”
To register, click here.
(Source: Endpoints Webinars, August 29th, 2022)